The global orally disintegrating tablet excipient market is expected to grow with a CAGR of 5.6% from 2025 to 2031. The major drivers for this market are the increasing demand for patient-friendly drug formulations, the rising prevalence of neurological disorders globally, and the growing adoption of fast-dissolving tablet technology.
The future of the global orally disintegrating tablet excipient market looks promising with opportunities in the anti-psychotics drug and anti-epileptics drug markets.
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
The future of the global orally disintegrating tablet excipient market looks promising with opportunities in the anti-psychotics drug and anti-epileptics drug markets.
- Within the type category, binder is expected to witness the highest growth over the forecast period.
- Within the application category, anti-epileptics drug is expected to witness higher growth.
- In terms of region, North America is expected to witness the highest growth over the forecast period.
Emerging Trends in the Orally Disintegrating Tablet Excipient Market
The market for orally disintegrating tablet excipient is evolving with innovations in formulation technology, regulatory advancements, and increasing consumer demand for fast-dissolving drug delivery systems.- Rising Demand for Natural Excipients: Consumers and regulators are favoring natural and plant-based excipients, leading to increased research and commercialization of sustainable alternatives.
- Advancements in Co-processed Excipients: New excipient combinations are improving drug stability, dissolution rates, and overall tablet performance, making formulations more effective.
- Expansion of Pediatric and Geriatric Applications: Orally disintegrating tablets are increasingly used in pediatric and geriatric medicine, driving demand for specialized excipients with enhanced safety and taste-masking properties.
- Regulatory Focus on Excipient Quality and Safety: Governments are tightening regulations on excipient manufacturing, ensuring better quality control and compliance in pharmaceutical applications.
- Growth in Biopharmaceutical Applications: Excipient manufacturers are developing advanced materials for biologic drugs, enhancing drug stability and patient adherence.
Recent Developments in the Orally Disintegrating Tablet Excipient Market
The orally disintegrating tablet excipient market is witnessing significant advancements in excipient technology, regulatory frameworks, and manufacturing processes, contributing to improved drug formulations.- Innovation in Sugar-based Excipients: New sugar-based excipients are being developed to enhance the taste and disintegration of orally disintegrating tablets, improving patient compliance.
- Increased Investment in Nanotechnology: Pharmaceutical firms are using nanotechnology to optimize excipient properties, resulting in better drug absorption and faster dissolution rates.
- Expansion of GMP-certified Manufacturing Facilities: Companies are upgrading facilities to meet good manufacturing practice (GMP) standards, ensuring high-quality excipient production.
- Regulatory Approvals for New Excipient Combinations: Authorities are approving novel excipient blends that improve tablet performance, stability, and dissolution characteristics.
- Adoption of Sustainable and Eco-friendly Excipients: Manufacturers are shifting toward biodegradable and non-toxic excipients to meet growing sustainability demands.
Strategic Growth Opportunities in the Orally Disintegrating Tablet Excipient Market
Growth opportunities in the orally disintegrating tablet excipient market are driven by advancements in formulation science, increasing demand for fast-dissolving medications, and regulatory changes promoting excipient innovation.- Development of Multifunctional Excipients: Innovations in excipients that combine multiple functional properties are reducing the need for additional formulation ingredients, streamlining drug development.
- Expansion in Personalized Medicine Applications: The increasing focus on precision medicine is leading to demand for customized excipient solutions that enhance drug efficacy for specific patient populations.
- Integration of Artificial Intelligence in Excipient Research: AI is being used to optimize excipient selection and formulation processes, improving efficiency and reducing development time.
- Growth in Pediatric and Geriatric Healthcare Segments: The rising need for patient-friendly drug delivery solutions is creating demand for specialized excipients tailored to these populations.
- Increased Collaboration Between Pharmaceutical and Excipient Companies: Strategic partnerships are driving innovation in excipient functionality, stability, and compatibility with active pharmaceutical ingredients.
Orally Disintegrating Tablet Excipient Market Driver and Challenges
The market is influenced by various drivers, such as technological advancements, regulatory support, and increasing patient demand. However, challenges related to cost, quality control, and regulatory compliance persist.The factors responsible for driving the orally disintegrating tablet excipient market include:
- Rising Demand for Patient-friendly Drug Delivery Systems: The increasing preference for orally disintegrating tablets among pediatric and geriatric populations is driving excipient market growth.
- Technological Advancements in Excipient Development: Innovations in co-processed excipients and nanotechnology are enhancing drug stability, dissolution rates, and overall tablet effectiveness.
- Stringent Regulatory Frameworks Ensuring Quality Compliance: Regulatory bodies are emphasizing excipient safety, pushing manufacturers to improve production quality and adherence to pharmaceutical standards.
- Expansion of the Generic Drug Market: Growth in generic drug production is increasing demand for cost-effective excipients that ensure bioequivalence and stability.
- Growing Focus on Sustainable and Natural Excipients: Consumer and regulatory pressure to use biodegradable and plant-based excipients is driving research in eco-friendly alternatives.
Challenges in the orally disintegrating tablet excipient market are:
- High Cost of Advanced Excipient Technologies: The development and adoption of innovative excipient formulations require significant investment, limiting access for smaller pharmaceutical firms.
- Complex Regulatory Approval Processes: Varying excipient regulations across different countries create challenges for manufacturers seeking global market entry.
- Supply Chain Disruptions and Raw Material Shortages: Fluctuations in raw material availability impact excipient production and pricing, affecting market stability.
List of Orally Disintegrating Tablet Excipient Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies orally disintegrating tablet excipient companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the orally disintegrating tablet excipient companies profiled in this report include:
- BASF
- JRS Pharma
- Roquette
- ABF Ingredients
- DFE Pharma
- Evonik
- Merck
- Ashland
- Meggle Pharma
- Shin-Etsu
Orally Disintegrating Tablet Excipient Market by Segment
The study includes a forecast for the global orally disintegrating tablet excipient market by type, application, and region.Type [Value from 2019 to 2031]:
- Binders
- Glidants
- Diluents
- Disintegrants
- Others
Application [Value from 2019 to 2031]:
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Others
Region [Value from 2019 to 2031]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country-wise Outlook for the Orally Disintegrating Tablet Excipient Market
The orally disintegrating tablet excipient market is experiencing significant growth due to rising demand for patient-friendly drug formulations. Advancements in excipient technology, regulatory approvals, and expanding production capabilities in key regions are driving market expansion.- United States: The United States is leading research in novel excipient formulations to enhance drug stability and bioavailability. The FDA is approving new excipient combinations, and pharmaceutical firms are investing in advanced manufacturing processes.
- China: China is expanding its excipient production capabilities to support the growing pharmaceutical industry. Government initiatives are promoting innovation, and local manufacturers are entering global supply chains.
- Germany: Germany is focusing on improving excipient quality through regulatory advancements. The country is also witnessing increased collaboration between pharmaceutical companies and excipient manufacturers to enhance tablet performance.
- India: India is emerging as a major supplier of excipients due to cost-effective production and increasing exports. However, challenges such as quality standardization and regulatory compliance need to be addressed.
- Japan: Japan is advancing research in natural and synthetic excipients for orally disintegrating tablets. The country is also implementing stricter regulations to ensure high-quality formulations.
Features of this Global Orally Disintegrating Tablet Excipient Market Report
- Market Size Estimates: Orally disintegrating tablet excipient market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
- Segmentation Analysis: Orally disintegrating tablet excipient market size by type, application, and region in terms of value ($B).
- Regional Analysis: Orally disintegrating tablet excipient market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the orally disintegrating tablet excipient market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the orally disintegrating tablet excipient market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the orally disintegrating tablet excipient market by type (binders, glidants, diluents, disintegrants, and others), application (anti-psychotics drug, anti-epileptics drug, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
3. Market Trends & Forecast Analysis
4. Global Orally Disintegrating Tablet Excipient Market by Type
5. Global Orally Disintegrating Tablet Excipient Market by Application
6. Regional Analysis
7. North American Orally Disintegrating Tablet Excipient Market
8. European Orally Disintegrating Tablet Excipient Market
9. APAC Orally Disintegrating Tablet Excipient Market
10. RoW Orally Disintegrating Tablet Excipient Market
11. Competitor Analysis
12. Opportunities & Strategic Analysis
13. Company Profiles of the Leading Players Across the Value Chain
14. Appendix
List of Figures
List of Tables
Companies Mentioned
The major companies profiled in this Orally Disintegrating Tablet Excipient market report include:- BASF
- JRS Pharma
- Roquette
- ABF Ingredients
- DFE Pharma
- Evonik
- Merck
- Ashland
- Meggle Pharma
- Shin-Etsu
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
